HYDERABAD, India, Feb. 5, 2026 /PRNewswire/ — According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow from USD 33.47 billion in 2026 to reach USD 58.66 billion by 2031, at a CAGR of 11.87% during the forecast period (2026-2031). The market expansion is supported by the growing focus on precision medicine, increasing prevalence of chronic diseases, and rising demand for advanced analytical tools to understand complex biological systems.

The proteomics market is being shaped by the expanding role of proteomic analysis in drug discovery, biomarker identification, and disease pathway analysis. Organizations are increasingly integrating proteomics into research workflows to improve target validation, enhance translational research, and support the development of targeted therapies. Continuous advancements in mass spectrometry, protein separation techniques, and data analysis platforms are further improving accuracy, sensitivity, and throughput, thereby supporting broader market adoption.

Proteomics Market Regional Share Analysis

North America represents a leading share of the proteomics market, driven by strong investment in biomedical research, advanced laboratory infrastructure, and the presence of major pharmaceutical and biotechnology companies. The region continues to adopt proteomics technologies across research, clinical, and commercial settings to support innovation in drug development and diagnostics.

Europe holds a significant proteomics market share, supported by active research programs, growing focus on personalized medicine, and collaborative initiatives between academic institutions and industry participants. Asia-Pacific is emerging as a high-growth region, fueled by expanding research capabilities, increasing government funding for life sciences, and rising biotechnology investment across the region.

Proteomics Market Trends & Forecast

Growing Adoption of Proteomics in Drug Discovery and Development

Proteomics is increasingly being used in drug discovery to identify disease biomarkers, study protein interactions, and improve understanding of therapeutic targets, supporting more efficient and targeted drug development processes.

Integration of Proteomics with Precision Medicine Initiatives

The integration of proteomics with genomics and other disciplines is strengthening its role in precision medicine, enabling more personalized approaches to disease diagnosis and treatment.

Proteomics Industry Segmentation Overview

By Component

Instruments
Reagents
Software and Services

By Technology

Mass Spectrometry
Spectroscopy
Chromatography
Next-Generation Sequencing
Protein Microarrays
Microfluidics
X-ray Crystallography
Other Technologies

By Application

Drug Discovery & Development
Clinical Diagnostics
Biomarker Discovery
Precision and Personalized Medicine
Agricultural & Environmental Proteomics
Other Applications

By End-User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
Other End-Users

By Geography

North America
Europe
Asia-Pacific
Middle East & Africa
South America

For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/global-proteomics-market-industry?utm_source=prnewswire

Proteomics Market Competitive Outlook

The proteomics industry comprises a mix of established life science technology providers and specialized proteomics solution companies. Market participants are focusing on expanding analytical capabilities, enhancing product portfolios, and forming strategic collaborations to address evolving research and clinical needs.

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bruker Corporation
Danaher Corporation
Thermo Fisher Scientific Inc.

Check out related reports published by Mordor Intelligence

Molecular Cytogenetics Market: The molecular cytogenetics market was valued at USD 3.18 billion in 2025 and is projected to grow from USD 3.47 billion in 2026 to reach USD 5.41 billion by 2031, registering a CAGR of 9.25% during the forecast period from 2026 to 2031, driven by the rapid adoption of personalized medicine, focused testing menus and the increasing emphasis on targeted therapies and companion diagnostics.

Gene Therapy Market: The gene therapy market is estimated to be valued at USD 10.04 billion in 2026 and is projected to reach USD 25.89 billion by 2031, registering a CAGR of 20.86% over the forecast period from 2026 to 2031, supported by the rising approval of one-time curative therapies and the expansion of venture capital and SPAC funding pipelines.

Exosomes Market: The exosomes market is estimated to be valued at USD 0.89 billion in 2026 and is projected to reach USD 2.78 billion by 2031, registering a CAGR of 25.55% during the forecast period from 2026 to 2031, supported by rapid advances in high-yield exosome isolation technologies that are reducing the cost of goods.

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 
 
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries, please contact:

[email protected]
https://www.mordorintelligence.com/contact-us

Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/proteomics-market-growing-at-an-11-87-cagr-to-2031-as-precision-medicine–drug-discovery-adoption-rise-says-a-2026-mordor-intelligence-report-302679967.html